An examination of psychomotor disturbance in current and remitted MDD: An RDoC Study
当前和缓解的 MDD 中精神运动障碍的检查:一项 RDoC 研究
基本信息
- 批准号:10374003
- 负责人:
- 金额:$ 65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-08 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAgitationAnimalsAreaBasal GangliaBehaviorBehavior assessmentBrainCellular PhoneCharacteristicsCicatrixClinicalCognitiveDataDepressed moodDiagnosisDiagnosticDiffusionDiseaseDisease remissionDyskinetic syndromeEarly DiagnosisEnvironmentExhibitsFatigueFunctional Magnetic Resonance ImagingGoalsGrainHeterogeneityHumanIndividualLaboratoriesLeadLinkLongitudinal StudiesMajor Depressive DisorderMeasurementMeasuresMediatingMental DepressionMotorMovementNational Institute of Mental HealthParkinson DiseasePatientsPhenotypePreventionProcessPublic HealthRelapseReportingResearchResearch Domain CriteriaRestRiskRoleSchizophreniaSeveritiesSignal TransductionSymptomsSystemTestingText MessagingTimeWorkactigraphybasebehavior measurementclinical practiceclinically significantcost effectivedepressive symptomsfollow up assessmentfollow-upgraph theoryhealth economicsinnovationlongitudinal designmotor behaviormotor symptommultimodal neuroimagingneural circuitneuromechanismnovelprospectiverecruitrelapse predictionsymptom clustersymptomatologytooltreatment responsetreatment strategywhite matter
项目摘要
Project Summary
Major depressive disorder (MDD) is a serious public health problem that has, at best, modest treatment
response. One reason for this mixed efficacy is that MDD has a very heterogeneous clinical presentation. One
way to parse the heterogeneity is to investigate the role of particular features of MDD, an endeavor that can
also help identify novel and focal targets for treatment and prevention efforts. Psychomotor disturbance (e.g.,
psychomotor agitation [PmA] and retardation [PmR]) has long been viewed as a particularly pernicious feature
of MDD, and yet we know surprisingly little about these behaviors. For example, it is unknown if motor
disturbance occurs only in active depression, or whether it also continues into remission (potentially signaling
vulnerability for relapse). There also has been little work (a) linking PmA & PmR with abnormal neural circuitry
mediating these motor behaviors, (b) examining how motor symptoms change over the course of illness, and
(c) investigating whether PmR & PmA represent a single underlying process, or reflect distinct mechanisms.
The present proposal seeks to test these questions and also identify powerful and easy to administer
tools to assess these behaviors in clinical practice. The proposed project will recruit those with current MDD (n
= 100), remitted MDD (n = 100) and controls (n = 50) and take a Research Domain Criteria (RDoC) approach
by comparing the three groups on multiple indicators of PmR and PmA (Aim 1). Specifically, we will assess
PmR and PmA with self and observer- based reports, behavioral assessments in the laboratory (Velocity
Scaling [PmR] and Force Variability [PmA]), and behavioral assessments in subjects' natural environment
(actigraphy and daily typing behavior on one's smartphone [texting, emailing, etc.]). These behavioral
measures are particularly critical as they yield more fine-grained and objective assessments of PmR and PmA
that may be missed by traditional diagnostic assessments. Aim 2 seeks to examine the structural (diffusion
tensor) and functional (resting state fMRI) connectivity of motor circuitry of the three groups as well as the
relation between motor circuitry and the proposed indicators of PmR and PmA. For this aim, we will utilize
innovative graph theory metrics of connectivity of the three primary motor circuits identified in animal and
human studies (specifically, basal ganglia, cerebellar and cortico-cortical motor circuits) which will provide a
comprehensive examination of motor system organization in MDD. Aim 3 seeks to follow-up subjects three
times over 18 months to evaluate whether motor symptoms change in tandem with overall depressive
symptoms and functioning over time and/or whether baseline PmR/PmA predicts course of depression an
functoining. Aim 3 is particularly clinically significant. Finding that motor and overall depression severity co-
vary over time, or that motor variables predict subsequent change in overall depression severity, would support
the potential clinical utility of the proposed novel, reliable, and easily administered motor assessments.
项目摘要
重度抑郁障碍(MDD)是一个严重的公共卫生问题,充其量只能得到适度的治疗
回应。这种混合疗效的一个原因是MDD具有非常不同的临床表现。一
解析异构性的方法是调查MDD的特定功能的作用,这一努力可以
还有助于确定治疗和预防工作的新的和重点目标。精神运动障碍(例如,
精神运动激越[PMA]和迟缓[PMR])长期以来一直被视为一种特别有害的特征
但令人惊讶的是,我们对这些行为知之甚少。例如,目前尚不清楚电机是否
干扰只发生在活动性抑郁症中,或者是否也持续到缓解期(潜在的信号
复发的脆弱性)。也很少有工作(A)将PMA和PMR与异常神经回路联系起来
调节这些运动行为,(B)检查运动症状在疾病过程中如何变化,以及
(C)调查PMR和PMA是否代表单一的基本进程,或反映不同的机制。
目前的提案试图测试这些问题,并找出强大和易于管理的
在临床实践中评估这些行为的工具。拟议的项目将招聘那些目前患有MDD的人(n
=100),缓解MDD(n=100)和对照(n=50),并采用研究领域标准(RDoC)方法
通过比较三组PMR和PMA的多项指标(目标1)。具体地说,我们将评估
PMR和PMA,包括基于自我和观察者的报告、实验室中的行为评估(Velocity
标度[PMR]和力变异性[PMA]),以及受试者自然环境中的行为评估
(智能手机上的动作记录和日常打字行为[短信、电子邮件等])。这些行为
衡量标准尤其关键,因为它们对PMR和PMA做出了更细粒度和更客观的评估
这一点可能会被传统的诊断评估遗漏。目标2试图检查结构(扩散)
张量)和功能(静息状态fMRI)的连通性,以及
电机电路与PMR和PMA拟议指标之间的关系。为此,我们将利用
创新图论度量动物和动物中识别的三个主要马达电路的连通性
人体研究(特别是基底节、小脑和皮质-皮质运动回路)将提供
MDD中运动系统组织的全面检查。目标3寻求跟进主题3
评估运动症状是否与总体抑郁同步变化的时间超过18个月
症状和功能随时间的变化和/或基线PMR/PMA是否预测抑郁症和
工作正常。目标3具有特别重要的临床意义。发现运动和整体抑郁的严重程度共同作用
随着时间的推移而变化,或者运动变量预测总体抑郁严重程度随后的变化,将支持
拟议的新的、可靠的和易于管理的运动评估的潜在临床应用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VIJAY A MITTAL其他文献
VIJAY A MITTAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VIJAY A MITTAL', 18)}}的其他基金
2/5 CAPER Computerized assessment of psychosis risk
2/5 CAPER 精神病风险的计算机化评估
- 批准号:
10592322 - 财政年份:2020
- 资助金额:
$ 65万 - 项目类别:
2/5 CAPER Computerized assessment of psychosis risk
2/5 CAPER 精神病风险的计算机化评估
- 批准号:
9978241 - 财政年份:2020
- 资助金额:
$ 65万 - 项目类别:
2/5 CAPER Computerized assessment of psychosis risk
2/5 CAPER 精神病风险的计算机化评估
- 批准号:
10399414 - 财政年份:2020
- 资助金额:
$ 65万 - 项目类别:
Prodromal Inventory for Negative Symptoms (PINS): A Development and Validation Study
阴性症状前驱清单 (PINS):开发和验证研究
- 批准号:
10320426 - 财政年份:2019
- 资助金额:
$ 65万 - 项目类别:
An examination of psychomotor disturbance in current and remitted MDD: An RDoC Study
当前和缓解的 MDD 中精神运动障碍的检查:一项 RDoC 研究
- 批准号:
9754473 - 财政年份:2019
- 资助金额:
$ 65万 - 项目类别:
An examination of psychomotor disturbance in current and remitted MDD: An RDoC Study
当前和缓解的 MDD 中精神运动障碍的检查:一项 RDoC 研究
- 批准号:
9910463 - 财政年份:2019
- 资助金额:
$ 65万 - 项目类别:
Prodromal Inventory for Negative Symptoms (PINS): A Development and Validation Study
阴性症状前驱清单 (PINS):开发和验证研究
- 批准号:
10031573 - 财政年份:2019
- 资助金额:
$ 65万 - 项目类别:
Prodromal Inventory for Negative Symptoms (PINS): A Development and Validation Study
阴性症状前驱清单 (PINS):开发和验证研究
- 批准号:
10528461 - 财政年份:2019
- 资助金额:
$ 65万 - 项目类别:
An examination of psychomotor disturbance in current and remitted MDD: An RDoC Study
当前和缓解的 MDD 中精神运动障碍的检查:一项 RDoC 研究
- 批准号:
10596065 - 财政年份:2019
- 资助金额:
$ 65万 - 项目类别:
2/3 Community psychosis risk screening: An instrument development study
2/3 社区精神病风险筛查:仪器开发研究
- 批准号:
10216970 - 财政年份:2017
- 资助金额:
$ 65万 - 项目类别:
相似海外基金
Relationship between Biomarkers of Oxidative Stress and Agitation Severity in Moderate-to-severe Alzheimer's Disease
中重度阿尔茨海默病氧化应激生物标志物与躁动严重程度之间的关系
- 批准号:
497994 - 财政年份:2023
- 资助金额:
$ 65万 - 项目类别:
Effects of dexmedetomidine on agitation in critically ill TBI patients - DEX-TBI
右美托咪定对危重 TBI 患者躁动的影响 - DEX-TBI
- 批准号:
488402 - 财政年份:2023
- 资助金额:
$ 65万 - 项目类别:
Operating Grants
Co-design and evaluation of sensor-instrumented ‘smart socks’ (MPATIX) to improve management of distress and agitation for people with dementia
共同设计和评估传感器仪表“智能袜子”(MPATIX),以改善痴呆症患者的痛苦和躁动管理
- 批准号:
10055596 - 财政年份:2023
- 资助金额:
$ 65万 - 项目类别:
Collaborative R&D
Identifying pre-agitation biometric signature in dementia patients: A feasibility study
识别痴呆症患者的躁动前生物识别特征:可行性研究
- 批准号:
486612 - 财政年份:2022
- 资助金额:
$ 65万 - 项目类别:
Studentship Programs
Relationship between 4-Hydroxynonenal and Agitation Severity in Alzheimer’s Disease
4-羟基壬烯醛与阿尔茨海默病患者躁动严重程度之间的关系
- 批准号:
486589 - 财政年份:2022
- 资助金额:
$ 65万 - 项目类别:
Studentship Programs
Agitation in Alzheimer's Disease: Identification and Prediction Using Digital Behavioral Markers and Indoor Environmental Factors
阿尔茨海默病中的躁动:使用数字行为标记和室内环境因素进行识别和预测
- 批准号:
10404523 - 财政年份:2021
- 资助金额:
$ 65万 - 项目类别:
Clinical Decision Support Tool to Assess Risk and Prevent Agitation Events
用于评估风险和预防躁动事件的临床决策支持工具
- 批准号:
10683499 - 财政年份:2021
- 资助金额:
$ 65万 - 项目类别:
Development of Memesto, a wearable repetitive message and music therapy device that senses and reduces agitation in persons with AD/ADRD.
开发 Memesto,一种可穿戴式重复信息和音乐治疗设备,可感知并减少 AD/ADRD 患者的躁动。
- 批准号:
10322846 - 财政年份:2021
- 资助金额:
$ 65万 - 项目类别:
Agitation in Alzheimer's Disease: Identification and Prediction Using Digital Behavioral Markers and Indoor Environmental Factors
阿尔茨海默病中的躁动:使用数字行为标记和室内环境因素进行识别和预测
- 批准号:
10190522 - 财政年份:2021
- 资助金额:
$ 65万 - 项目类别:
Clinical Decision Support Tool to Assess Risk and Prevent Agitation Events
用于评估风险和预防躁动事件的临床决策支持工具
- 批准号:
10365272 - 财政年份:2021
- 资助金额:
$ 65万 - 项目类别: